Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Correlative Biomarker Study in Patients With Myeloproliferative Disorders

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Icahn School of Medicine at Mount Sinai
Sponsor:
Collaborators:
Myeloproliferative Disorders-Research Consortium
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT00665067
First received: April 21, 2008
Last updated: August 3, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)